New scan could help decide who benefits from heart surgery
NCT ID NCT07657650
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study is testing whether a special type of imaging called FAPI can better predict how much heart function will improve after bypass surgery or stenting in people with ischemic heart failure. Researchers will follow 122 patients for 12 months, measuring changes in heart pumping ability and tracking major heart events. The goal is to see if FAPI imaging provides more useful information than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a more reliable imaging test to decide which heart failure patients will benefit from bypass surgery or stenting.
- What could go wrong
- This is an observational study, not a treatment trial. The imaging method may not prove better than existing tests, and results may not change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Chaoyang Hospital, Capital Medical University
RECRUITINGBeijing, 100020, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Rehab program shows promise in tracking blood flow recovery
- Stem cell injection during bypass surgery aims to repair damaged hearts
- Heart failure patients get RNA boost during bypass in first human test
- Stem cell patch aims to mend broken hearts in landmark trial
- Could your own bone marrow repair a failing heart?
- Lab-grown heart cells injected into failing hearts: a new hope?